RHYTHM PHARMACEUTICALS, INC. Increase (Decrease) in Accounts Payable and Accrued Liabilities
RHYTHM PHARMACEUTICALS, INC. (RYTM) reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of $10.84 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2026-08-04
- RHYTHM PHARMACEUTICALS, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-06-30 was $16.46M, a 24.15% increase year-over-year.
- RHYTHM PHARMACEUTICALS, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-03-31 was -$5.62M.
- RHYTHM PHARMACEUTICALS, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-12-31 was $1.25M, a 91.73% decline year-over-year.
- RHYTHM PHARMACEUTICALS, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-09-30 was $11.02M, a 46.71% increase year-over-year.
- RHYTHM PHARMACEUTICALS, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2025 was $21.89M, a 0.12% decline from fiscal 2024.
- RHYTHM PHARMACEUTICALS, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2024 was $21.92M, a 48.37% increase from fiscal 2023.
- RHYTHM PHARMACEUTICALS, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2023 was $14.77M, a 857.42% increase from fiscal 2022.
- RHYTHM PHARMACEUTICALS, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2022 was $1.54M, a 91.57% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $16.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $10.84M 10-Q · filed 2026-08-04 | $12.09M derived: sum of 3 quarters · filed 2026-08-04 | $23.11M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | -$5.62M 10-Q · filed 2026-05-05 | -$4.36M derived: sum of 2 quarters · filed 2026-05-05 | $6.65M derived: sum of 3 quarters · filed 2026-05-05 | $19.91M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $1.25M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $12.27M derived: sum of 2 quarters · filed 2026-02-26 | $25.52M derived: sum of 3 quarters · filed 2026-08-04 | $21.89M 10-K · filed 2026-02-26 |
| 2025-09-30 | $11.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $24.27M derived: sum of 2 quarters · filed 2026-08-04 | $20.64M 10-Q · filed 2025-11-04 | $35.82M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $13.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $9.62M 10-Q · filed 2026-08-04 | $24.80M derived: sum of 3 quarters · filed 2026-08-04 | $32.31M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | -$3.63M 10-Q · filed 2026-05-05 | $11.55M derived: sum of 2 quarters · filed 2026-05-05 | $19.05M derived: sum of 3 quarters · filed 2026-05-05 | $19.54M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $15.18M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $22.69M derived: sum of 2 quarters · filed 2026-02-26 | $23.17M derived: sum of 3 quarters · filed 2026-02-26 | $21.92M 10-K · filed 2026-02-26 |
| 2024-09-30 | $7.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $7.99M derived: sum of 2 quarters · filed 2025-11-04 | $6.74M 10-Q · filed 2025-11-04 | $11.60M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $482.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | -$769.00K 10-Q · filed 2025-08-05 | $4.09M derived: sum of 3 quarters · filed 2026-02-26 | $8.18M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | -$1.25M 10-Q · filed 2025-05-07 | $3.61M derived: sum of 2 quarters · filed 2026-02-26 | $7.69M derived: sum of 3 quarters · filed 2026-02-26 | $8.36M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $4.86M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $8.95M derived: sum of 2 quarters · filed 2026-02-26 | $9.61M derived: sum of 3 quarters · filed 2026-02-26 | $14.77M 10-K · filed 2026-02-26 |
| 2023-09-30 | $4.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $4.75M derived: sum of 2 quarters · filed 2024-11-06 | $9.91M 10-Q · filed 2024-11-06 | $25.63M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | $661.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $5.83M 10-Q · filed 2024-08-06 | $21.54M derived: sum of 3 quarters · filed 2025-02-28 | $8.97M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | $5.17M 10-Q · filed 2024-05-07 | $20.88M derived: sum of 2 quarters · filed 2025-02-28 | $8.31M derived: sum of 3 quarters · filed 2025-02-28 | $6.76M derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | $15.71M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $3.14M derived: sum of 2 quarters · filed 2025-02-28 | $1.60M derived: sum of 3 quarters · filed 2025-02-28 | $1.54M 10-K · filed 2025-02-28 |
| 2022-09-30 | -$12.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | -$14.12M derived: sum of 2 quarters · filed 2023-11-08 | -$14.17M 10-Q · filed 2023-11-08 | -$1.25M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | -$1.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01 | -$1.60M 10-Q · filed 2023-08-01 | $11.32M derived: sum of 3 quarters · filed 2024-02-29 | $17.31M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | -$53.00K 10-Q · filed 2023-05-02 | $12.87M derived: sum of 2 quarters · filed 2024-02-29 | $18.86M derived: sum of 3 quarters · filed 2024-02-29 | $24.53M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $12.92M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $18.91M derived: sum of 2 quarters · filed 2024-02-29 | $24.58M derived: sum of 3 quarters · filed 2024-02-29 | $18.31M 10-K · filed 2024-02-29 |
| 2021-09-30 | $5.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $11.66M derived: sum of 2 quarters · filed 2022-11-08 | $5.39M 10-Q · filed 2022-11-08 | $7.33M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | $5.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | -$598.00K 10-Q · filed 2022-08-03 | $1.34M derived: sum of 3 quarters · filed 2023-03-01 | $1.88M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | -$6.27M 10-Q · filed 2022-05-03 | -$4.33M derived: sum of 2 quarters · filed 2023-03-01 | -$3.79M derived: sum of 3 quarters · filed 2023-03-01 | -$6.04M derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | $1.94M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $2.48M derived: sum of 2 quarters · filed 2023-03-01 | $227.00K derived: sum of 3 quarters · filed 2023-03-01 | -$6.45M 10-K · filed 2023-03-01 |
| 2020-09-30 | $536.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | -$1.71M derived: sum of 2 quarters · filed 2021-11-02 | -$8.39M 10-Q · filed 2021-11-02 | -$8.92M derived: sum of 4 quarters · filed 2021-11-02 |
| 2020-06-30 | -$2.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | -$8.92M 10-Q · filed 2021-08-03 | -$9.46M derived: sum of 3 quarters · filed 2021-08-03 | -$10.69M derived: sum of 4 quarters · filed 2021-08-03 |
| 2020-03-31 | -$6.67M 10-Q · filed 2021-05-03 | -$7.21M derived: sum of 2 quarters · filed 2021-05-03 | -$8.44M derived: sum of 3 quarters · filed 2021-05-03 | $5.91M derived: sum of 4 quarters · filed 2021-05-03 |
| 2019-12-31 | -$536.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | -$1.77M derived: sum of 2 quarters · filed 2021-03-01 | $12.58M derived: sum of 3 quarters · filed 2021-03-01 | $10.51M 10-K · filed 2021-03-01 |
| 2019-09-30 | -$1.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-02 | $13.12M derived: sum of 2 quarters · filed 2020-11-02 | $11.04M 10-Q · filed 2020-11-02 | $16.77M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | $14.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-03 | $12.27M 10-Q · filed 2020-08-03 | $18.00M derived: sum of 3 quarters · filed 2021-03-01 | $18.66M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | -$2.07M 10-Q · filed 2020-05-04 | $3.65M derived: sum of 2 quarters · filed 2021-03-01 | $4.31M derived: sum of 3 quarters · filed 2021-03-01 | $6.10M derived: sum of 4 quarters · filed 2021-03-01 |
| 2018-12-31 | $5.73M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $6.38M derived: sum of 2 quarters · filed 2021-03-01 | $8.17M derived: sum of 3 quarters · filed 2021-03-01 | $6.95M 10-K · filed 2021-03-01 |
| 2018-09-30 | $655.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-01 | $2.44M derived: sum of 2 quarters · filed 2019-11-01 | $1.22M 10-Q · filed 2019-11-01 | $2.34M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-06-30 | $1.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-29 | $569.00K 10-Q · filed 2019-07-29 | $1.69M derived: sum of 3 quarters · filed 2020-03-02 | $2.30M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-03-31 | -$1.22M 10-Q · filed 2019-05-03 | -$104.00K derived: sum of 2 quarters · filed 2020-03-02 | $514.00K derived: sum of 3 quarters · filed 2020-03-02 | $1.19M derived: sum of 4 quarters · filed 2020-03-02 |
| 2017-12-31 | $1.12M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $1.73M derived: sum of 2 quarters · filed 2020-03-02 | $2.41M derived: sum of 3 quarters · filed 2020-03-02 | $1.95M 10-K · filed 2020-03-02 |
| 2017-09-30 | $618.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $1.29M derived: sum of 2 quarters · filed 2018-11-09 | $830.00K 10-Q · filed 2018-11-09 | $1.32M derived: sum of 4 quarters · filed 2019-03-08 |
| 2017-06-30 | $676.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $212.00K 10-Q · filed 2018-08-08 | $707.00K derived: sum of 3 quarters · filed 2019-03-08 | |
| 2017-03-31 | -$464.00K 10-Q · filed 2018-05-14 | $31.00K derived: sum of 2 quarters · filed 2019-03-08 | ||
| 2016-12-31 | $495.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-08 | $160.00K 10-K · filed 2019-03-08 | ||
| 2016-09-30 | -$335.00K 10-Q · filed 2017-11-14 | |||
| 2015-12-31 | $3.84M 8-K · filed 2018-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |